일성아이에스
003120KOSPI· 의료용 물질 및 의약품 제조업22,000원+200 (+0.92%)마감후장 마감 후
52주 위치
17,12029,30040%신고가 대비 -24.91%
- 시가총액
- 2,926억
- PER
- 27.50
- PBR
- 0.77
- EPS(TTM)
- 800원
- BPS
- 28,554원
- 자사주비율
- 46.15%
- 결산월
- 12월
알림 만들기관심종목·메모·논지·저널은 로그인하면 사용 가능
| 항목 | 2021(별도) | 2022(별도) | 2023(별도) | 2024(별도) | 2025(별도) |
|---|---|---|---|---|---|
| ROE | -0.40% | 26.59% | -5.06% | 3.41% | 0.30% |
| ROA | -0.37% | 24.31% | -4.58% | 3.21% | 0.29% |
| 영업이익률 | -4.27% | 2.12% | -10.24% | -13.79% | -9.58% |
| 순이익률 | -3.25% | 171.83% | -26.83% | 18.97% | 1.81% |
| 매출총이익률 | 38.33% | 45.61% | 46.23% | 39.19% | 43.37% |
| 부채비율 | 7.36% | 10.96% | 9.52% | 3.05% | 4.31% |
| 유동비율 | 1350.73% | 808.09% | 842.43% | 2607.34% | 1746.88% |
| 매출 성장률(YoY) | — | 45.52% | 27.44% | -11.58% | -6.85% |
| 영업이익 성장률(YoY) | — | — | -716.12% | — | — |
| 순이익 성장률(YoY) | — | — | -119.90% | — | -91.10% |
| FCF | -52.26억 | -1,010억 | -492억 | -157억 | 17.46억 |
| FCF 마진 | -12.42% | -164.87% | -63.04% | -22.76% | 2.72% |
| CAPEX/매출 | 25.97% | 101.25% | 9.90% | 16.60% | 3.32% |
| 항목 | 2021 3Q(별도) | 2021 4Q(별도) | 2022 1Q(별도) | 2022 2Q(별도) | 2022 3Q(별도) | 2022 4Q(별도) | 2023 1Q(별도) | 2023 2Q(별도) | 2023 3Q(별도) | 2023 4Q(별도) | 2024 1Q(별도) | 2024 2Q(별도) | 2024 3Q(별도) | 2024 4Q(별도) | 2025 1Q(별도) | 2025 2Q(별도) | 2025 3Q(별도) | 2025 4Q(별도) | 2026 1Q(별도) | 2026 2Q(별도) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 0.22% | 0.98% | 0.16% | 22.65% | 0.83% | 0.38% | 4.03% | -0.28% | 1.04% | -9.59% | -0.17% | -0.11% | 2.40% | 1.19% | 0.41% | -1.10% | 0.09% | 0.88% | 0.42% | 0.06% |
| ROA | 0.20% | 0.91% | 0.14% | 20.51% | 0.76% | 0.35% | 3.57% | -0.26% | 0.94% | -8.69% | -0.15% | -0.10% | 2.27% | 1.12% | 0.38% | -1.04% | 0.09% | 0.85% | 0.39% | 0.06% |
| 영업이익률 | -4.19% | -0.68% | 2.21% | -10.94% | 4.71% | 9.55% | -17.23% | -13.06% | -8.12% | -3.72% | -20.99% | -17.85% | 4.60% | -23.58% | -6.13% | -14.06% | -5.04% | -13.71% | -2.97% | -9.15% |
| 순이익률 | 7.09% | 26.83% | 3.52% | 765.88% | 20.54% | 8.88% | 86.43% | -6.06% | 24.80% | -180.30% | -4.17% | -2.46% | 50.57% | 27.05% | 9.26% | -25.35% | 2.03% | 23.25% | 9.44% | 1.27% |
| 매출총이익률 | 38.80% | 41.69% | 40.85% | 45.46% | 46.64% | 48.95% | 48.94% | 53.85% | 41.60% | 40.91% | 39.10% | 36.23% | 49.05% | 31.16% | 44.35% | 41.83% | 44.03% | 43.21% | 46.99% | 44.34% |
| 부채비율 | 7.29% | 7.36% | 8.19% | 10.47% | 11.34% | 10.96% | 16.79% | 8.56% | 8.23% | 9.52% | 12.15% | 8.75% | 3.58% | 3.05% | 5.33% | 3.42% | 3.59% | 4.31% | 6.33% | 3.76% |
| 유동비율 | 1386.92% | 1350.73% | 1161.34% | 1003.81% | 926.09% | 808.09% | 550.37% | 1323.89% | 1409.79% | 842.43% | 668.92% | 897.51% | 2242.86% | 2607.34% | 1436.95% | 2291.95% | 2306.60% | 1746.88% | 1223.57% | 2041.58% |
| 매출 성장률(YoY) | — | — | — | — | 50.77% | 36.40% | 19.00% | 53.54% | 13.04% | 28.43% | -10.84% | -14.41% | 5.23% | -23.39% | 3.97% | -5.18% | -11.87% | -13.14% | 0.53% | 5.14% |
| 영업이익 성장률(YoY) | — | — | — | — | — | — | -1026.47% | — | -294.91% | -150.00% | — | — | — | — | — | — | -196.59% | — | — | — |
| 순이익 성장률(YoY) | — | — | — | — | 336.79% | -54.87% | 2820.65% | -101.22% | 36.49% | -2708.33% | -104.30% | — | 114.63% | — | — | — | -96.45% | -25.34% | 2.51% | — |
| FCF | -26.43억 | -42.65억 | -6,372만 | 2,875억 | 31.8억 | -3,916억 | -87.15억 | -156억 | -103억 | -146억 | -1.69억 | 6.5억 | -73.76억 | -93.79억 | 12.47억 | 47.36억 | -14.47억 | -34.07억 | -10.88억 | -3.61억 |
| FCF 마진 | -24.92% | -33.93% | -0.42% | 2204.24% | 19.89% | -2283.90% | -48.60% | -77.95% | -57.01% | -66.17% | -1.06% | 3.79% | -38.78% | -55.59% | 7.50% | 29.14% | -8.63% | -23.25% | -6.51% | -2.11% |
| CAPEX/매출 | 34.87% | 28.88% | 0.27% | 32.27% | 2.25% | 334.75% | 3.92% | 7.48% | 14.40% | 13.28% | 14.15% | 1.64% | 1.06% | 54.96% | 5.87% | 2.42% | 6.42% | 2.10% | 2.14% | 2.84% |
출처 DART 재무제표 원값으로 자체 계산· 갱신 2026-09-21 00:30· 별도 · 산식은 항목 툴팁